Niels Clauson-Kaas A/S Our business activities consist of laboratory through pilot plant syntheses of small molecules or development of new or modified production processes. Our main focus today is to manufacture Active Pharmaceutical Ingredients (APIs) for pre-clinical as well as for PI/PII clinical studies according to cGMP, including analytical services; development and validation of analytical methods and stability studies according to ICH guidelines.